• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number IS2-JP
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/26/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Additional information: a6: race noted as japanese.The device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A complaint history review was completed.The electronic complaint system was searched for the specified lot#.There were no similar issues reported for this lot #.A review of the device labeling including the risk analysis was completed.The reported issue (trocar fragmentation) is identified to be an anticipated hazard.The residual risk for each potential harm was found to be within the insignificant risk region.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.Mfr# reference: (b)(4).
 
Event or Problem Description
It was reported that following the successful implantation of the first stent (of two stents) from a trabecular microbypass stent system, the trocar broke during the implantation of the second stent.Reportedly, the trocar fragment was removed intraoperatively, and the procedure was completed.The report noted that the trocar was pressed "harder than usual" against the trabecular meshwork (tm) causing the trocar to "curve" when the delivery button was pressed.Additional information has been requested.
 
Additional Manufacturer Narrative
Mfr# reference: (b)(4).
 
Event or Problem Description
Through follow-up, the following additional information was received.Per report, the surgeon believes that the insertion tube firmly pressed against the trabecular meshwork (tm) resulted in a bent trocar while the delivery button was pressed, and contributed to the event.There was no adverse patient impact, no postoperative intervention required, and the patient is reportedly stable and doing well with the event resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2
Common Device Name
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key24612329
Report Number2032546-2026-00017
Device Sequence Number9678122
Product Code OGO
UDI-Device Identifier00853704002487
UDI-Public01008537040024871032960817270731
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P170043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberIS2-JP
Device Lot Number329608
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/27/2026
Supplement Date Received by Manufacturer04/08/2026
Initial Report FDA Received Date03/16/2026
Supplement Report FDA Received Date04/13/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/29/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
Patient RaceAsian
-
-